| Medical and Health Sciences | Lifetime | 382 | US 208 | 99.98 |
| Agricultural, Food and Veterinary Sciences | Lifetime | 657 | US 189 | 99.48 |
| Medical and Health Sciences | 2021-2025 | 463 | US 158 | 99.90 |
| Epidemiology | Lifetime | 9 | US 7 | 99.99 |
| Infectious Diseases | Lifetime | 21 | US 10 | 99.91 |
| Agronomy and Crop Science | Lifetime | 253 | US 107 | 98.58 |
| Immunology | Lifetime | 615 | US 315 | 98.17 |
| Animal Science and Livestock Production | Lifetime | 325 | US 114 | 97.77 |
| Infectious Diseases | 2021-2025 | 14 | US 5 | 99.80 |
| Epidemiology | 2021-2025 | 60 | US 17 | 99.66 |
| Immunology | 2021-2025 | 596 | US 217 | 82.91 |
| Respiratory viral infections research | Lifetime | 2 | US 2 | 99.98 |
| Influenza Virus Research Studies | Lifetime | 2 | US 2 | 99.98 |
| Animal Disease Management and Epidemiology | Lifetime | 6 | US 3 | 99.91 |
| Animal Virus Infections Studies | Lifetime | 10 | US 6 | 99.87 |
| Viral Infections and Outbreaks Research | Lifetime | 3 | US 2 | 99.91 |
| Viral gastroenteritis research and epidemiology | Lifetime | 10 | US 8 | 99.92 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 34 | US 10 | 99.80 |
| interferon and immune responses | Lifetime | 12 | US 9 | 99.85 |
| Viral Infections and Vectors | Lifetime | 26 | US 16 | 99.83 |
| COVID-19 Clinical Research Studies | Lifetime | 109 | US 29 | 99.33 |
| Virus-based gene therapy research | Lifetime | 157 | US 116 | 99.35 |
| SARS-CoV-2 detection and testing | Lifetime | 49 | US 15 | 98.64 |
| Viral Infections and Immunology Research | Lifetime | 120 | US 63 | 98.98 |
| Immune Response and Inflammation | Lifetime | 244 | US 118 | 99.34 |
| Monoclonal and Polyclonal Antibodies Research | Lifetime | 542 | US 303 | 99.06 |
| Hepatitis B Virus Studies | Lifetime | 332 | US 119 | 99.04 |
| Virology and Viral Diseases | Lifetime | 119 | US 70 | 98.67 |
| COVID-19 epidemiological studies | Lifetime | 158 | US 62 | 98.59 |
| RNA and protein synthesis mechanisms | Lifetime | 457 | US 281 | 99.05 |
| Yersinia bacterium, plague, ectoparasites research | Lifetime | 209 | US 87 | 96.72 |
| Pharmacological Effects of Natural Compounds | Lifetime | 619 | US 97 | 96.23 |
| vaccines and immunoinformatics approaches | Lifetime | 394 | US 191 | 95.77 |
| Zoonotic diseases and public health | Lifetime | 497 | US 190 | 94.01 |
| Phagocytosis and Immune Regulation | Lifetime | 458 | US 191 | 93.55 |
| Infectious Encephalopathies and Encephalitis | Lifetime | 885 | US 338 | 81.86 |
| Influenza Virus Research Studies | 2021-2025 | 3 | US 1 | 99.71 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 18 | US 9 | 99.82 |
| Respiratory viral infections research | 2021-2025 | 9 | US 2 | 99.69 |
| Viral gastroenteritis research and epidemiology | 2021-2025 | 11 | US 7 | 99.14 |
| COVID-19 Clinical Research Studies | 2021-2025 | 65 | US 22 | 99.55 |
| SARS-CoV-2 detection and testing | 2021-2025 | 20 | US 9 | 99.01 |
| Animal Virus Infections Studies | 2021-2025 | 54 | US 19 | 97.54 |
| COVID-19 epidemiological studies | 2021-2025 | 114 | US 21 | 97.94 |
| Animal Disease Management and Epidemiology | 2021-2025 | 161 | US 36 | 95.42 |
| Immune Response and Inflammation | 2021-2025 | 456 | US 107 | 83.39 |
| Viral Infections and Outbreaks Research | 2021-2025 | 557 | US 171 | 84.33 |
| vaccines and immunoinformatics approaches | 2021-2025 | 803 | US 198 | 75.99 |
